200 related articles for article (PubMed ID: 12833894)
21. Importance of early diagnosis in managing ovarian cancer.
Dunleavey R
Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
[TBL] [Abstract][Full Text] [Related]
22. The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.
Bădulescu F; Bădulescu A; Schenker M; Popescu CF; Stoica Z
Rom J Morphol Embryol; 2005; 46(4):329-34. PubMed ID: 16688372
[TBL] [Abstract][Full Text] [Related]
23. [Malignant epithelial tumors of the ovary. Current diagnostic and therapeutic aspects].
Pescetto G
G Clin Med; 1989 Jan; 70(1):3-18. PubMed ID: 2527175
[No Abstract] [Full Text] [Related]
24. Recent advances in the management of women with ovarian cancer.
Eltabbakh GH
Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
[TBL] [Abstract][Full Text] [Related]
25. [Epithelial ovarian cancer--preoperative assessment of Ca 125 levels as an independent prognostic factor].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2003; 42(3):16-9. PubMed ID: 12858485
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of ovarian cancer.
Sundar S; Neal RD; Kehoe S
BMJ; 2015 Sep; 351():h4443. PubMed ID: 26328593
[No Abstract] [Full Text] [Related]
27. [Current aspects of diagnosis, therapy and follow-up care of ovarian carcinoma].
Lotze W
Z Arztl Fortbild (Jena); 1991 Mar; 85(6):242-5. PubMed ID: 2038849
[No Abstract] [Full Text] [Related]
28. Future directions in the management of epithelial ovarian cancer.
Blagden S; Gabra H
Future Oncol; 2008 Jun; 4(3):403-11. PubMed ID: 18518765
[TBL] [Abstract][Full Text] [Related]
29. The role of regular physical examination in the detection of ovarian cancer recurrence.
Chan KK; Tam KF; Tse KY; Ngan HY
Gynecol Oncol; 2008 Aug; 110(2):158-61. PubMed ID: 18544459
[TBL] [Abstract][Full Text] [Related]
30. [Role of genome research in the diagnosis and therapy of ovarian cancer].
Malek AV; Bakhidze EV
Vopr Onkol; 2005; 51(2):182-6. PubMed ID: 16222997
[No Abstract] [Full Text] [Related]
31. [The treatment of epithelial carcinoma of ovary (an analysis of 89 cases) (author's transl)].
Cheng YJ
Zhonghua Fu Chan Ke Za Zhi; 1979; 14(3):178-81. PubMed ID: 555728
[No Abstract] [Full Text] [Related]
32. Can we now agree to use the same definition to measure response according to CA-125?
Rustin GJ
J Clin Oncol; 2004 Oct; 22(20):4035-6. PubMed ID: 15364965
[No Abstract] [Full Text] [Related]
33. The cost of surveillance following treatment of ovarian cancer.
Rustin GJ
Gynecol Oncol; 2013 Dec; 131(3):501-2. PubMed ID: 24267818
[No Abstract] [Full Text] [Related]
34. Post-therapy surveillance and after-care in ovarian cancer.
von Georgi R; Schubert K; Grant P; Münstedt K
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):228-33. PubMed ID: 15140520
[TBL] [Abstract][Full Text] [Related]
35. [Initial management of patients with malignant epithelial ovarian tumors].
Kerbrat P
Presse Med; 2000 Dec; 29(38):2100-4. PubMed ID: 11147053
[No Abstract] [Full Text] [Related]
36. CA125 measurement in epithelial ovarian cancer: a 10-year anniversary of clinical investigation.
Berkowitz RS
Gynecol Oncol; 1993 Apr; 49(1):1-2. PubMed ID: 8482551
[No Abstract] [Full Text] [Related]
37. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
Huang X; Cai SM; Tang J; Li ZT; Zang RY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
Baker PM; Oliva E
Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of risk factors for epithelial ovarian cancer recurrence].
Liu S; Liu JH; Huang H; Peng XP; Wang YM
Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
[TBL] [Abstract][Full Text] [Related]
40. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
